Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.

Current molecular medicine - 1 Jan 2014

Jack J, Rotroff D, Motsinger-Reif A

Abstract excerpt

A new standard for medicine is emerging that aims to improve individual drug responses through studying associations with genetic variations. This field, pharmacogenomics, is undergoing a rapid expansion due to a variety of technological advancements that are enabling higher throughput with reductions in cost. Here we review the advantages, limitations, and opportunities for using lymphoblastoid cell lines (LCL)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Transformed
Share to Cost-Benefit Analysis
Share to Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Biological

Share to Pharmacogenetics

Share to Reproducibility of Results

Share to RNA Interference

Share to Translational Research, Biomedical

Source

Open in PubMed Open full text

Identifiers

PMID: 25109794
DOI: 10.2174/1566524014666140811113946
PMCID: PMC4323076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.PMID 25109794Read ↗

Lymphoblastoid Cell Lines in Pharmacogenomic Discovery and Clinical TranslationSemantic proximity Read ↗

Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.Semantic proximity Read ↗

Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.Semantic proximity Read ↗

Use of cell lines in the investigation of pharmacogenetic loci.Semantic proximity Read ↗

Clinical translation of cell-based pharmacogenomic discovery.Semantic proximity Read ↗

Chapter 7: PharmacogenomicsSemantic proximity Read ↗

Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines.Semantic proximity Read ↗

Drug Response Pharmacogenetics for 200,000 UK Biobank Participants.Semantic proximity Read ↗

Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines.Semantic proximity Read ↗

Pharmacogenomics: candidate gene identification, functional validation and mechanisms.Semantic proximity Read ↗

In vitro human cell line models to predict clinical response to anticancer drugs.Semantic proximity Read ↗

The development of pharmacogenomic models to predict drug response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.